| Hans-Günter Meyer-Thompson | Naltrexon
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up
Gaulen, Zhanna et al.
Journal of Substance Abuse Treatment, Volume 0, Issue 0, 108656
https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(21)00382-2/fulltext